Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
HUM > SEC Filings for HUM > Form 8-K on 9-Jan-2014All Recent SEC Filings

Show all filings for HUMANA INC

Form 8-K for HUMANA INC


Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.

Officers of Humana Inc. (the "Company") will be meeting with investors and analysts at an industry conference on January 13, 2014. During the meetings, the company intends to address its prospects and performance. The Company will not opine on any financial results or expectations for 2013 or 2014 at this conference beyond those listed below since it is in the process of closing its books for 2013.

Medicare Advantage and Stand-alone PDP Enrollment

Based upon the results of the Medicare Annual Election Period, the Company expects gross sales and terminations for individual Medicare Advantage plans for 2014 to be meaningfully better than previously projected resulting in higher anticipated net Medicare Advantage membership gains for 2014. Additionally, gross sales and terminations for the Company's stand-alone Prescription Drug Plans ("PDP") for 2014 are anticipated to be meaningfully better than previously projected resulting in higher anticipated net stand-alone PDP membership gains for 2014.

Health Insurance Exchanges

As a result of the December 2013 federal and state regulatory changes allowing certain individuals to remain in their previously existing off-exchange health plans, the Company now expects the risk mix of members enrolling through the health insurance exchanges to be more adverse than previously expected.

Earnings Estimate for 2014

The Company is evaluating the effects of its revised Medicare enrollment and health insurance exchange risk mix expectations but is reaffirming its previous 2014 earnings guidance of $7.25 to $7.75 per diluted common share.

2015 Medicare Advantage Funding Pressures

In a December 2013 call, the Centers for Medicare and Medicaid Services ("CMS") updated its medical cost trend assumptions associated with Original Medicare fee-for-service. This preliminary medical cost trend data from CMS would increase the Company's prior estimate of 2015 Medicare Advantage funding pressure of 4 to 5 percent to a range of 6 to 7 percent.

The Company expects to continue its standard process of seeking alternatives to minimize the disruption to Medicare beneficiaries this level of rate decline may cause. Such alternatives include clinical management programs, operating cost efficiencies, benefit changes, market exits and other operating strategies. In the interim, the Company also expects to continue its efforts to educate CMS, the Administration and Congress on the adverse impact such rate pressures have upon Medicare beneficiaries.

  Add HUM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for HUM - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.